ArticleRSC advances2025
Tuning ZnO photocatalysts
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, C- and Ce-doped ZnO materials were synthesized by two methods: hydrothermal method (CCZ-HT) and microwave method (CCZ-MA), both using the same starting materials. The different heating stages of the methods produce distinct morphologies, doping concentrations, and some other characteristics. CCZ-HT consists of nanoellipsoids, while CCZ-MA consists of nanoflakes. The doping concentrations of cerium and carbon in CCZ-MA are higher than those in CCZ-HT. The types of crystal defects in the doped materials are different, leading to differences in their absorption and emission properties. The band gap energy of CCZ-MA is 2.85 eV, which is lower than that of CCZ-HT (2.92 eV). While CCZ-HT does not exhibit near-infrared emissions, CCZ-MA exhibits relatively strong emissions. CCZ-HT and CCZ-MA had a degradation capacity for ofloxacin (Ofx) under visible light that was 2.63 and 3.38 times superior to that of pure ZnO, respectively. The addition of Ce and C improved the band structure by slightly moving the conduction band and reducing the band gap, which allowed for better light absorption in the visible range and helped separate charge carriers. These enhancements immediately facilitated enhanced photocatalytic efficacy in the breakdown of ofloxacin. The CCZ-MA material exhibited superior photocatalytic activity due to its advantageous shape, increased surface area, and enhanced charge trapping capability associated with flaws. The functions of photo oxidized fragments and reaction intermediates were also examined. This study postulated a photodegradation mechanism for Ofx.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.